95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB5281

 

Introduced , by Rep. Charles E. Jefferson

 

SYNOPSIS AS INTRODUCED:
 
225 ILCS 25/50.5 new
225 ILCS 60/33   from Ch. 111, par. 4400-33
225 ILCS 65/65-40  was 225 ILCS 65/15-20
225 ILCS 80/6   from Ch. 111, par. 3906
225 ILCS 85/18   from Ch. 111, par. 4138
225 ILCS 95/7.5
225 ILCS 100/20.10 new
225 ILCS 120/50.5 new

    Amends the Illinois Dental Practice Act, the Medical Practice Act of 1987, the Nurse Practice Act, the Illinois Optometric Practice Act of 1987, the Pharmacy Practice Act, the Physician Assistant Practice Act of 1987, and the Podiatric Medical Practice Act of 1987. Provides that no licensee or registrant under the Acts shall be compelled to release his or her prescription records to any person or entity licensed under the Wholesale Drug Distribution Licensing Act or any other pharmaceutical sales company and may take all acceptable measures necessary to safeguard these records from unwanted release. Prohibits licensees or registrants under the Acts from releasing any prescription record to a person or entity licensed under the Wholesale Drug Distribution Licensing Act or any other pharmaceutical sales company, unless the licensee or registrant has obtained a release waiver from the patient for whom the prescription was initiated or the patient's authorized agent. Amends the Wholesale Drug Distribution Licensing Act to prohibit the compulsion of the release of prescription records from a licensee or registrant and the receipt of prescription records without the provision of proof of a patient waiver.


LRB095 18210 RAS 44294 b

FISCAL NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB5281 LRB095 18210 RAS 44294 b

1     AN ACT concerning regulation.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Illinois Dental Practice Act is amended by
5 adding Section 50.5 as follows:
 
6     (225 ILCS 25/50.5 new)
7     (Section scheduled to be repealed on January 1, 2016)
8     Sec. 50.5. Prescription record release prohibited. No
9 dentist shall be compelled to release his or her prescription
10 records to any person or entity licensed under the Wholesale
11 Drug Distribution Licensing Act or any other pharmaceutical
12 sales company and may take all measures necessary and deemed
13 acceptable by the Department to safeguard these records from
14 unwanted release. A dentist is prohibited from releasing any
15 prescription record to a person or entity licensed under the
16 Wholesale Drug Distribution Licensing Act or any other
17 pharmaceutical sales company, unless the dentist has obtained a
18 release waiver from the patient for whom the prescription was
19 initiated or the patient's authorized agent.
 
20     Section 10. The Medical Practice Act of 1987 is amended by
21 changing Section 33 as follows:
 

 

 

HB5281 - 2 - LRB095 18210 RAS 44294 b

1     (225 ILCS 60/33)  (from Ch. 111, par. 4400-33)
2     (Section scheduled to be repealed on December 31, 2008)
3     Sec. 33. Any person licensed under this Act to practice
4 medicine in all of its branches shall be authorized to purchase
5 legend drugs requiring an order of a person authorized to
6 prescribe drugs, and to dispense such legend drugs in the
7 regular course of practicing medicine. The dispensing of such
8 legend drugs shall be the personal act of the person licensed
9 under this Act and may not be delegated to any other person not
10 licensed under this Act or the Pharmacy Practice Act unless
11 such delegated dispensing functions are under the direct
12 supervision of the physician authorized to dispense legend
13 drugs. Except when dispensing manufacturers' samples or other
14 legend drugs in a maximum 72 hour supply, persons licensed
15 under this Act shall maintain a book or file of prescriptions
16 as required in the Pharmacy Practice Act. No licensee shall be
17 compelled to release his or her prescription records to any
18 person or entity licensed under the Wholesale Drug Distribution
19 Licensing Act or any other pharmaceutical sales company and may
20 take all measures necessary and deemed acceptable by the
21 Department to safeguard these records from unwanted release. A
22 licensee is prohibited from releasing any prescription record
23 to a person or entity licensed under the Wholesale Drug
24 Distribution Licensing Act or any other pharmaceutical sales
25 company, unless the licensee has obtained a release waiver from
26 the patient for whom the prescription was initiated or the

 

 

HB5281 - 3 - LRB095 18210 RAS 44294 b

1 patient's authorized agent.
2     Any person licensed under this Act who dispenses any drug
3 or medicine shall dispense such drug or medicine in good faith
4 and shall affix to the box, bottle, vessel or package
5 containing the same a label indicating (a) the date on which
6 such drug or medicine is dispensed; (b) the name of the
7 patient; (c) the last name of the person dispensing such drug
8 or medicine; (d) the directions for use thereof; and (e) the
9 proprietary name or names or, if there are none, the
10 established name or names of the drug or medicine, the dosage
11 and quantity, except as otherwise authorized by regulation of
12 the Department of Professional Regulation. The foregoing
13 labeling requirements shall not apply to drugs or medicines in
14 a package which bears a label of the manufacturer containing
15 information describing its contents which is in compliance with
16 requirements of the Federal Food, Drug, and Cosmetic Act and
17 the Illinois Food, Drug, and Cosmetic Act. "Drug" and
18 "medicine" have the meaning ascribed to them in the Pharmacy
19 Practice Act, as now or hereafter amended; "good faith" has the
20 meaning ascribed to it in subsection (v) of Section 102 of the
21 "Illinois Controlled Substances Act", approved August 16,
22 1971, as amended.
23     Prior to dispensing a prescription to a patient, the
24 physician shall offer a written prescription to the patient
25 which the patient may elect to have filled by the physician or
26 any licensed pharmacy.

 

 

HB5281 - 4 - LRB095 18210 RAS 44294 b

1     A violation of any provision of this Section shall
2 constitute a violation of this Act and shall be grounds for
3 disciplinary action provided for in this Act.
4 (Source: P.A. 95-689, eff. 10-29-07.)
 
5     Section 15. The Nurse Practice Act is amended by changing
6 Section 65-40 as follows:
 
7     (225 ILCS 65/65-40)   (was 225 ILCS 65/15-20)
8     (Section scheduled to be repealed on January 1, 2018)
9     Sec. 65-40. Prescriptive authority.
10     (a) A collaborating physician or podiatrist may, but is not
11 required to, delegate prescriptive authority to an advanced
12 practice nurse as part of a written collaborative agreement.
13 This authority may, but is not required to, include
14 prescription of, selection of, orders for, administration of,
15 storage of, acceptance of samples of, and dispensing over the
16 counter medications, legend drugs, medical gases, and
17 controlled substances categorized as Schedule III, III-N, IV,
18 or V controlled substances, as defined in Article II of the
19 Illinois Controlled Substances Act, and other preparations,
20 including, but not limited to, botanical and herbal remedies.
21 The collaborating physician or podiatrist must have a valid
22 current Illinois controlled substance license and federal
23 registration to delegate authority to prescribe delegated
24 controlled substances.

 

 

HB5281 - 5 - LRB095 18210 RAS 44294 b

1     (b) To prescribe controlled substances under this Section,
2 an advanced practice nurse must obtain a mid-level practitioner
3 controlled substance license. Medication orders shall be
4 reviewed periodically by the collaborating physician or
5 podiatrist.
6     (c) The collaborating physician or podiatrist shall file
7 with the Department notice of delegation of prescriptive
8 authority and termination of such delegation, in accordance
9 with rules of the Department. Upon receipt of this notice
10 delegating authority to prescribe Schedule III, III-N, IV, or V
11 controlled substances, the licensed advanced practice nurse
12 shall be eligible to register for a mid-level practitioner
13 controlled substance license under Section 303.05 of the
14 Illinois Controlled Substances Act.
15     (d) In addition to the requirements of subsections (a),
16 (b), and (c) of this Section, a collaborating physician may,
17 but is not required to, delegate authority to an advanced
18 practice nurse to prescribe Schedule II or II-N controlled
19 substances, if all of the following conditions apply:
20         (1) No more than 5 Schedule II or II-N controlled
21     substances by oral dosage may be delegated.
22         (2) Any delegation must be controlled substances that
23     the collaborating physician prescribes.
24         (3) Any prescription must be limited to no more than a
25     30-day oral dosage, with any continuation authorized only
26     after prior approval of the collaborating physician.

 

 

HB5281 - 6 - LRB095 18210 RAS 44294 b

1         (4) The advanced practice nurse must discuss the
2     condition of any patients for whom a controlled substance
3     is prescribed monthly with the delegating physician.
4     (e) Nothing in this Act shall be construed to limit the
5 delegation of tasks or duties by a physician to a licensed
6 practical nurse, a registered professional nurse, or other
7 persons.
8     (f) No advanced practice nurse with prescriptive authority
9 shall be compelled to release his or her prescription records
10 to any person or entity licensed under the Wholesale Drug
11 Distribution Licensing Act or any other pharmaceutical sales
12 company and may take all measures necessary and deemed
13 acceptable by the Department to safeguard these records from
14 unwanted release. An advanced practice nurse with prescriptive
15 authority is prohibited from releasing any prescription record
16 to a person or entity licensed under the Wholesale Drug
17 Distribution Licensing Act or any other pharmaceutical sales
18 company, unless the advanced practice nurse has obtained a
19 release waiver from the patient for whom the prescription was
20 initiated or the patient's authorized agent.
21 (Source: P.A. 95-639, eff. 10-5-07.)
 
22     Section 20. The Illinois Optometric Practice Act of 1987 is
23 amended by changing Section 6 as follows:
 
24     (225 ILCS 80/6)  (from Ch. 111, par. 3906)

 

 

HB5281 - 7 - LRB095 18210 RAS 44294 b

1     (Section scheduled to be repealed on January 1, 2017)
2     Sec. 6. Display of license; change of address; record of
3 examinations and prescriptions. Every holder of a license under
4 this Act shall display such license on a conspicuous place in
5 the office or offices wherein such holder practices optometry
6 and every holder shall, whenever requested, exhibit such
7 license to any representative of the Department, and shall
8 notify the Department of the address or addresses and of every
9 change thereof, where such holder shall practice optometry.
10     Every licensed optometrist shall keep a record of
11 examinations made and prescriptions issued, which record shall
12 include the names of persons examined and for whom
13 prescriptions were prepared, and shall be signed by the
14 licensed optometrist and retained by him in the office in which
15 such professional service was rendered. Such records shall be
16 preserved by the optometrist for a period designated by the
17 Department. A copy of such records shall be provided, upon
18 written request, to the person examined, or his or her
19 designee. No licensed optometrist shall be compelled to release
20 his or her prescription records to any person or entity
21 licensed under the Wholesale Drug Distribution Licensing Act or
22 any other pharmaceutical sales company and may take all
23 measures necessary and deemed acceptable by the Department to
24 safeguard these records from unwanted release. A licensed
25 optometrist is prohibited from releasing any prescription
26 record to a person or entity licensed under the Wholesale Drug

 

 

HB5281 - 8 - LRB095 18210 RAS 44294 b

1 Distribution Licensing Act or any other pharmaceutical sales
2 company, unless the optometrist has obtained a release waiver
3 from the patient for whom the prescription was initiated or the
4 patient's authorized agent.
5 (Source: P.A. 94-787, eff. 5-19-06.)
 
6     Section 25. The Pharmacy Practice Act is amended by
7 changing Section 18 as follows:
 
8     (225 ILCS 85/18)  (from Ch. 111, par. 4138)
9     (Section scheduled to be repealed on January 1, 2018)
10     Sec. 18. Record retention. Except as provided in subsection
11 (b), there shall be kept in every drugstore or pharmacy a
12 suitable book, file, or electronic record keeping system in
13 which shall be preserved for a period of not less than 5 years
14 the original, or an exact, unalterable image, of every written
15 prescription and the original transcript or copy of every
16 verbal prescription filled, compounded, or dispensed, in such
17 pharmacy; and such book or file of prescriptions shall at all
18 reasonable times be open to inspection to the pharmacy
19 coordinator and the duly authorized agents or employees of the
20 Department.
21     Every prescription filled or refilled shall contain the
22 unique identifiers of the persons authorized to practice
23 pharmacy under the provision of this Act who fills or refills
24 the prescription.

 

 

HB5281 - 9 - LRB095 18210 RAS 44294 b

1     Records kept pursuant to this Section may be maintained in
2 an alternative data retention system, such as a direct digital
3 imaging system, provided that:
4         (1) the records maintained in the alternative data
5     retention system contain all of the information required in
6     a manual record;
7         (2) the data processing system is capable of producing
8     a hard copy of the electronic record on the request of the
9     Board, its representative, or other authorized local,
10     State, or federal law enforcement or regulatory agency;
11         (3) the digital images are recorded and stored only by
12     means of a technology that does not allow subsequent
13     revision or replacement of the images; and
14         (4) the prescriptions may be retained in written form
15     or recorded in a data processing system, provided that such
16     order can be produced in printed form upon lawful request.
17     As used in this Section, "digital imaging system" means a
18 system, including people, machines, methods of organization,
19 and procedures, that provides input, storage, processing,
20 communications, output, and control functions for digitized
21 representations of original prescription records.
22     Inpatient drug orders may be maintained within an
23 institution in a manner approved by the Department.
24     No licensee or registrant shall be compelled to release
25 prescription records to any person or entity licensed under the
26 Wholesale Drug Distribution Licensing Act or any other

 

 

HB5281 - 10 - LRB095 18210 RAS 44294 b

1 pharmaceutical sales company and may take all measures
2 necessary and deemed acceptable by the Department to safeguard
3 these records from unwanted release. A licensee or registrant
4 is prohibited from releasing any prescription record to a
5 person or entity licensed under the Wholesale Drug Distribution
6 Licensing Act or any other pharmaceutical sales company, unless
7 the licensee or registrant has obtained a release waiver from
8 the patient for whom the prescription was initiated or the
9 patient's authorized agent.
10 (Source: P.A. 94-84, eff. 6-28-05; 95-689, eff. 10-29-07.)
 
11     Section 30. The Physician Assistant Practice Act of 1987 is
12 amended by changing Section 7.5 as follows:
 
13     (225 ILCS 95/7.5)
14     (Section scheduled to be repealed on January 1, 2018)
15     Sec. 7.5. Prescriptions. A supervising physician may
16 delegate limited prescriptive authority to a physician
17 assistant. This authority may, but is not required to, include
18 prescription and dispensing of legend drugs and legend
19 controlled substances categorized as Schedule III, IV, or V
20 controlled substances, as defined in Article II of the Illinois
21 Controlled Substances Act, as delegated in the written
22 guidelines required by this Act. To prescribe Schedule III, IV,
23 or V controlled substances under this Section, a physician
24 assistant must obtain a mid-level practitioner controlled

 

 

HB5281 - 11 - LRB095 18210 RAS 44294 b

1 substances license. Medication orders issued by a physician
2 assistant shall be reviewed periodically by the supervising
3 physician. The supervising physician shall file with the
4 Department notice of delegation of prescriptive authority to a
5 physician assistant and termination of delegation, specifying
6 the authority delegated or terminated. Upon receipt of this
7 notice delegating authority to prescribe Schedule III, IV, or V
8 controlled substances, the physician assistant shall be
9 eligible to register for a mid-level practitioner controlled
10 substances license under Section 303.05 of the Illinois
11 Controlled Substances Act. Nothing in this Act shall be
12 construed to limit the delegation of tasks or duties by the
13 supervising physician to a nurse or other appropriately trained
14 personnel.
15     No physician assistant with prescriptive authority shall
16 be compelled to release his or her prescription records to any
17 person or entity licensed under the Wholesale Drug Distribution
18 Licensing Act or any other pharmaceutical sales company and may
19 take all measures necessary and deemed acceptable by the
20 Department to safeguard these records from unwanted release. A
21 physician assistant with prescriptive authority is prohibited
22 from releasing any prescription record to a person or entity
23 licensed under the Wholesale Drug Distribution Licensing Act or
24 any other pharmaceutical sales company, unless the physician
25 assistant has obtained a release waiver from the patient for
26 whom the prescription was initiated or the patient's authorized

 

 

HB5281 - 12 - LRB095 18210 RAS 44294 b

1 agent.
2     The Department shall establish by rule the minimum
3 requirements for written guidelines to be followed under this
4 Section.
5 (Source: P.A. 90-116, eff. 7-14-97; 90-818, eff. 3-23-99.)
 
6     Section 35. The Podiatric Medical Practice Act of 1987 is
7 amended by adding Section 20.10 as follows:
 
8     (225 ILCS 100/20.10 new)
9     (Section scheduled to be repealed on January 1, 2018)
10     Sec. 20.10. Prescription record release prohibited. No
11 licensee shall be compelled to release his or her prescription
12 records to any person or entity licensed under the Wholesale
13 Drug Distribution Licensing Act or any other pharmaceutical
14 sales company and may take all measures necessary and deemed
15 acceptable by the Department to safeguard these records from
16 unwanted release. A licensee is prohibited from releasing any
17 prescription record to a person or entity licensed under the
18 Wholesale Drug Distribution Licensing Act or any other
19 pharmaceutical sales company, unless the licensee has obtained
20 a release waiver from the patient for whom the prescription was
21 initiated or the patient's authorized agent.
 
22     Section 40. The Wholesale Drug Distribution Licensing Act
23 is amended by adding Section 50.5 as follows:
 

 

 

HB5281 - 13 - LRB095 18210 RAS 44294 b

1     (225 ILCS 120/50.5 new)
2     (Section scheduled to be repealed on January 1, 2013)
3     Sec. 50.5. Prescription record release prohibited. No
4 licensee under this Act shall compel or attempt to compel a
5 prescribing agent, as that term is defined by the Department,
6 to release prescription records. A licensee under this Act is
7 prohibited from receiving any prescription record from a
8 prescribing agent, unless that prescribing agent presents
9 proof that he or she has obtained a release waiver from the
10 patient for whom the prescription was initiated or the
11 patient's authorized agent.